The medullary thyroid cancer drugs market is estimated to be valued at USD 156 Mn in 2024 and is expected to reach USD 315 Mn by 2031, growing at a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031. https://hallbook.com.br/blogs/429502/Medullary-Thyroid-Cancer-Drugs-Market-Poised-to-Surge-Driven-by